I’m very pleased to hear you say that Cabinet Secretary because, in fact, in England, the NHS uses a centralised route of funding to pay for these injections, which ensures that at least the minimum guidelines are met. I’m sure you’re aware, but evidence is demonstrating that by considering small cohorts of at-risk babies, there’s a clear economic case for using Synagis due to the subsequent reduction in hospital admissions. However, there is widespread variation on the decision making in Wales with regard to babies being able to access medicine, with health boards taking different approaches and it’s slipping between the gaps in specialities. So, will you consider looking at a change in either the way the vaccine is funded or looking at changes in how you might be able to issue more guidance on this matter?